News
Sarah’s Story–Treating Autism with Stem Cells
In 2010, Anna and her husband decided to bank their son, Ryan’s, cord blood with New England Cord Blood Bank, Inc. (NECBB). Two years later, when their daughter Sarah was born, they opted to save her cord blood as well. Later, when Sarah was diagnosed with Autism, Anna thought about the possibility of using cord blood stem…
Can cord blood therapy help arthritis patients?
Clinical and laboratory results document psoriatic arthritis in a 56-year old patient. The symptoms did not resolve with standard treatments (nonsteroidal anti-inflammatory drugs, steroids and methotrexate). TNF-alpha inhibitors (certolizumab pegol and adalimumab) were added to the treatment regime, with some adverse effects. A trial of human umbilical cord stem cell therapy was then initiated. The…
New developments in stem cell treatment for eye diseases
Stem cells are undifferentiated cells which have the ability to self-renew and differentiate into mature cells. They are highly proliferative, implying that an unlimited number of mature cells can be generated from a given stem cell source. On this basis, stem cell replacement therapy has been evaluated in recent years as an alternative for…
Major hospital joins pioneering cord blood cardiac treatment study
LOS ANGELES–(BUSINESS WIRE)–Children’s Hospital Los Angeles is announcing participation in the first-ever clinical trial using stem cells from umbilical cord blood to delay or even prevent heart failure in children born with a rare congenital heart defect that leaves them with half a heart. “It is very exciting that Children’s Hospital Los Angeles has joined…
Improvement for MS patients undergoing stem cell therapy
To investigate the clinical efficacy and safety of umbilical cord mesenchymal stem cell (UCMSC) transplantation for treating multiple sclerosis (MS), the patients with MS were recruited and treated with UCMSC. The procedure of preparing UCMSC was in accordance with the standards formulated by the International Society for Cell Biology. Cell surface markers, multiple differentiation…
Can cord blood stem cells help stroke patients?
Stroke is a major cause of death and long-term disability, affecting one in six people worldwide. The only currently available approved pharmacological treatment for ischemic stroke is tissue plasminogen activator; however, relatively few patients are eligible for this therapy. We hypothesized that intravenous (IV) infusion of banked unrelated allogeneic umbilical cord blood (UCB) would improve…
Duke University gets green light to offer more cord blood therapy
Duke University Medical Center has received permission from the FDA to offer cord blood therapy for conditions like autism spectrum disorder and cerebral palsy under an expanded access clinical trial. This protocol establishes an umbrella clinical trial NCT03327467 registered on 31 Oct. 2017 which enables children who have these neurological disorders to receive therapy with…
Worried you’re not spending enough time with your family?
Turns out, helicopter parenting pays off in one surprising way—modern parents spend more time with their children than parents of any other time since the 1960s. Guila M. Dotti Sani of the European University Institute and Judith Treas of the University of California, Irvine found that modern mothers from 11 wealthy, western countries spent close to…
It’s official! Weekend sleep-ins banish sleep debt
A consistent sleep schedule is key to unlocking healthy benefits such as skin that feels fresh and rejuvenated and a strong heart and immune system. A new study says that you can catch up on sleep on the weekend and undo some of the damage caused by lack of zzz’s Monday through Friday—like feeling like…
New hope that stem cells can reverse premature menopause and restore fertility
Young women with premature ovarian insufficiency (POI) may be able to use their own bone marrow stem cells to rejuvenate their ovaries and avoid the effects of premature menopause, new research suggests. The preliminary results from the ongoing ROSE clinical trial will be presented Tuesday at ENDO 2018, the 100th annual meeting of the…